Showing codes Q5120 (Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg) — Q9 (One class b and two class c findings)

Q5120 - Inj pegfilgrastim-bmez 0.5mg
Long description: Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg
Code added date: 20200701.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5121 - Inj. avsola, 10 mg
Long description: Injection, infliximab-axxq, biosimilar, (avsola), 10 mg
Code added date: 20200701.
Code effective date: 20231001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5122 - Inj, nyvepria
Long description: Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
Code added date: 20210101.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5123 - Inj. riabni, 10 mg
Long description: Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
Code added date: 20210701.
Code effective date: 20210701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5124 - Inj. byooviz, 0.1 mg
Long description: Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
Code added date: 20220401.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5125 - Inj, releuko 1 mcg
Long description: Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Code added date: 20221001.
Code effective date: 20221001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5126 - Inj alymsys 10 mg
Long description: Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
Code added date: 20230101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5127 - Inj, stimufend, 0.5 mg
Long description: Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
Code added date: 20230401.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5128 - Inj, cimerli, 0.1 mg
Long description: Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
Code added date: 20230401.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5129 - Inj, vegzelma, 10 mg
Long description: Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
Code added date: 20230401.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5130 - Inj, fylnetra, 0.5 mg
Long description: Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
Code added date: 20230401.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5131 - Inj, idacio, 20 mg
Long description: Injection, adalimumab-aacf (idacio), biosimilar, 20 mg
Code added date: 20230701.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5132 - Inj, abrilada, 10 mg
Long description: Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg
Code added date: 20240101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5133 - Inj, tofidence, 1 mg
Long description: Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
Code added date: 20240401.
Code effective date: 20241001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5134 - Inj, tyruko, 1 mg
Long description: Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5135 - Inj, tyenne, 1 mg
Long description: Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg
Code added date: 20241001.
Code effective date: 20241001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5136 - Inj. denosumab-bbdz, 1 mg
Long description: Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg
Code added date: 20241001.
Code effective date: 20241001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5137 - Inj, wezlana, sub cu, 1 mg
Long description: Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg
Code added date: 20240701.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5138 - Inj, wezlana, iv, 1 mg
Long description: Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg
Code added date: 20240701.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5139 - Inj, eculizumab-aeeb, 10 mg
Long description: Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5140 - Inj adalimumab-fkjp, 1 mg
Long description: Injection, adalimumab-fkjp, biosimilar, 1 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5141 - Inj adalimumab-aaty, 1 mg
Long description: Injection, adalimumab-aaty, biosimilar, 1 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5142 - Inj adalimumab-ryvk, 1 mg
Long description: Injection, adalimumab-ryvk biosimilar, 1 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5143 - Inj adalimumab-adbm, 1 mg
Long description: Injection, adalimumab-adbm, biosimilar, 1 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5144 - Inj, idacio, 1 mg
Long description: Injection, adalimumab-aacf (idacio), biosimilar, 1 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5145 - Inj, abrilada, 1 mg
Long description: Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5146 - Inj, hercessi, 10 mg
Long description: Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q6 - Fee/time comp subst md or pt
Long description: Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
Code added date: 19930101.
Code effective date: 20170701.
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q7 - One class a finding
Long description: One class a finding
Code added date: 19950101.
Code effective date: 19970101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q8 - Two class b findings
Long description: Two class b findings
Code added date: 19950101.
Code effective date: 19970101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q9 - 1 class b & 2 class c fndngs
Long description: One class b and two class c findings
Code added date: 19950101.
Code effective date: 19970101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF